Japanese biotech and pharma companies, including Sosei Group Corp. , have tended to build their businesses by acquiring foreign assets. Sosei's acquisition of Activus Pharma Co. Ltd. , a Japanese nanoparticle-based formulation company, breaks the mold. The...